Back to mobile site

JPMorgan Reiterates Overweight Rating on Eli Lilly (LLY)

September 2, 2026 9:29 AM EDT Send to a Friend
JPMorgan analyst Chris Schott reiterated an Overweight rating and $1,400.00 price target on Eli Lilly (NYSE: LLY).The analyst commented, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login